Literature DB >> 9010292

Inhibition of measles virus infection and fusion with peptides corresponding to the leucine zipper region of the fusion protein.

T F Wild1, R Buckland.   

Abstract

Measles virus (MV) infections are characterized by the induction of syncytia, i.e. the fusion of infected cells. Two MV proteins, the haemagglutinin (HA) and fusion (F) proteins, are involved in this process. Synthetic peptides representing two alpha-helical regions of the MV F protein were studied for their ability to inhibit MV fusion. A peptide corresponding to the leucine zipper region (amino acids 455-490) inhibited MV fusion, whereas a peptide to amino acids 148-177, corresponding to the amphipathic alpha-helix region, did not. Fusion inhibition was also obtained with vaccinia virus-expressed HA and F, a recent wild-type MV isolate and the closely related canine distemper virus, but not with mumps virus. The F455-490 peptide did not affect the synthesis of MV F or its transport to the cell membrane. Virus-cell attachment was unaffected, but haemolysis and virus entry into the cell were inhibited. In one-step growth curves the virus yield was unaffected.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9010292     DOI: 10.1099/0022-1317-78-1-107

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  37 in total

1.  Mutations in the fusion peptide and adjacent heptad repeat inhibit folding or activity of the Newcastle disease virus fusion protein.

Authors:  T A Sergel; L W McGinnes; T G Morrison
Journal:  J Virol       Date:  2001-09       Impact factor: 5.103

2.  Targeting a binding pocket within the trimer-of-hairpins: small-molecule inhibition of viral fusion.

Authors:  Christopher Cianci; David R Langley; Douglas D Dischino; Yaxiong Sun; Kuo-Long Yu; Anne Stanley; Julia Roach; Zhufang Li; Richard Dalterio; Richard Colonno; Nicholas A Meanwell; Mark Krystal
Journal:  Proc Natl Acad Sci U S A       Date:  2004-10-06       Impact factor: 11.205

3.  Side chain packing below the fusion peptide strongly modulates triggering of the Hendra virus F protein.

Authors:  Everett Clinton Smith; Rebecca Ellis Dutch
Journal:  J Virol       Date:  2010-08-11       Impact factor: 5.103

4.  Inhibition of hendra virus fusion.

Authors:  M Porotto; L Doctor; P Carta; M Fornabaio; O Greengard; G E Kellogg; A Moscona
Journal:  J Virol       Date:  2006-10       Impact factor: 5.103

5.  Identification of an immunodominant neutralizing and protective epitope from measles virus fusion protein by using human sera from acute infection.

Authors:  S F Atabani; O E Obeid; D Chargelegue; P Aaby; H Whittle; M W Steward
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

6.  Kinetic dependence of paramyxovirus entry inhibition.

Authors:  Matteo Porotto; Christine C Yokoyama; Gianmarco Orefice; Han-Sung Kim; Mohamed Aljofan; Bruce A Mungall; Anne Moscona
Journal:  J Virol       Date:  2009-04-15       Impact factor: 5.103

7.  Structure-Stability-Function Mechanistic Links in the Anti-Measles Virus Action of Tocopherol-Derivatized Peptide Nanoparticles.

Authors:  Tiago N Figueira; Diogo A Mendonça; Diana Gaspar; Manuel N Melo; Anne Moscona; Matteo Porotto; Miguel A R B Castanho; Ana Salomé Veiga
Journal:  ACS Nano       Date:  2018-09-24       Impact factor: 15.881

8.  Mutant fusion proteins with enhanced fusion activity promote measles virus spread in human neuronal cells and brains of suckling hamsters.

Authors:  Shumpei Watanabe; Yuta Shirogane; Satoshi O Suzuki; Satoshi Ikegame; Ritsuko Koga; Yusuke Yanagi
Journal:  J Virol       Date:  2012-12-19       Impact factor: 5.103

9.  Inhibition of Nipah virus infection in vivo: targeting an early stage of paramyxovirus fusion activation during viral entry.

Authors:  Matteo Porotto; Barry Rockx; Christine C Yokoyama; Aparna Talekar; Ilaria Devito; Laura M Palermo; Jie Liu; Riccardo Cortese; Min Lu; Heinz Feldmann; Antonello Pessi; Anne Moscona
Journal:  PLoS Pathog       Date:  2010-10-28       Impact factor: 6.823

10.  Targeted strategies for henipavirus therapeutics.

Authors:  Katharine N Bossart; John Bingham; Deborah Middleton
Journal:  Open Virol J       Date:  2007-09-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.